
Leaps by Bayer
Europe, Nordrhein-Westfalen, Germany, Leverkusen
Description
Leaps by Bayer invests in life sciences and specializes in the fields of biotechnology, agriculture, and scientific breakthrough.
Investor Profile
Leaps by Bayer has made 105 investments, with 11 in the past 12 months and 41% as lead.
Stage Focus
- Series A (38%)
- Series B (30%)
- Series C (10%)
- Series D (8%)
- Series Unknown (8%)
- Seed (4%)
- Post Ipo Equity (2%)
- Corporate Round (1%)
- Convertible Note (1%)
Country Focus
- United States (86%)
- Canada (6%)
- United Kingdom (3%)
- Kenya (2%)
- Germany (1%)
- Singapore (1%)
- China (1%)
- Brazil (1%)
Industry Focus
- Biotechnology
- Health Care
- Agriculture
- Therapeutics
- Medical
- Life Science
- Agtech
- Biopharma
- Artificial Intelligence (Ai)
- Machine Learning
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.